SMIM3 and acute myeloid leukemia: The expression of SMIM3 in 236 AML patients was significantly higher than in 22 healthy individuals (median 501.55%, Inter Quartile Range IQR [264.632–913.75%] vs 160.775%, IQR [50.741–220.642%], P < 0.001, Fig. 1D).